Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
Conditions: Shingles; Zoster Intervention: Biological: recombinant zoster vaccine Sponsor: Prof Patrice Lalive Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2022 Category: Research Source Type: clinical trials